Programmed Cell Death News and Research

RSS

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

A novel diagnostic model using machine learning (ML).

24 Apr 2024

Study reveals key protein's role in balancing immune response to viral infections

Researchers have revealed the regulatory mechanism of a specific protein that plays a key role in balancing the immune response triggered by viral infections in mammal cells.

18 Apr 2024

U-M study reveals potential pathway to reverse lung fibrosis

The most common type of lung fibrosis -; scarring of the lungs -- is idiopathic, meaning of unknown cause.

13 Apr 2024

NUS study reveals key mechanisms behind drug resistance in relapsed acute myeloid leukemia

Scientists from the National University of Singapore (NUS) have discovered that the evasion of apoptosis is a key driver of drug resistance in patients with relapsed acute myeloid leukaemia (AML), a type of aggressive blood cancer.

19 Mar 2024

Study reveals key mechanism of PD-1 function

Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows.

9 Mar 2024

Gut bacteria strains could be the key to predicting cancer treatment success

Researchers discovered that gut microbiota strains can predict the effectiveness and adverse effects of immune checkpoint blockade (ICB) therapy in rare cancer patients.

6 Mar 2024

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.

26 Feb 2024

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

22 Feb 2024

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Announcing a new publication for Acta Materia Medica journal. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but pose a challenge of immune-related adverse events (irAEs), particularly endocrine toxicity, that can severely compromise patient well-being.

21 Feb 2024

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

The change in overall survival (OS) among advanced melanoma patients diagnosed between 2013 and 2021.

14 Feb 2024

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Extracted from the core of sandalwood trees (santalum album tree), sandalwood oil has been used for many centuries by several cultures throughout the world for perfume, soaps, incense and candles.

13 Feb 2024

Hydrogel with built-in antibiofilm and antioxidative functions promotes faster healing of infected chronic wounds

A novel hydrogel dressing was developed recently to combat both these undesirable characteristics and tested for its effects on diabetic-infected wound healing.

5 Feb 2024

Study sheds light on 7-DHC's potential to induce cell death-resistant state in tumors

Cell death is fundamental to life and, thus, healthy aging. In the realm of cellular biology, ferroptosis (a form of programmed cell death) has emerged not only as a focal point of research for its potential in eliminating cancer cells, but also its role in a plethora of other diseases, including neurodegenerative diseases such as Alzheimer's disease, eye diseases such as Retinitis pigmentosa and age-related macular degeneration, as well as ischemia, cardiovascular disease, liver disease, acute kidney injury and inflammation.

1 Feb 2024

Programmed Cell Death News and Research

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

Study reveals key protein's role in balancing immune response to viral infections

U-M study reveals potential pathway to reverse lung fibrosis

NUS study reveals key mechanisms behind drug resistance in relapsed acute myeloid leukemia

Study reveals key mechanism of PD-1 function

Gut bacteria strains could be the key to predicting cancer treatment success

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Hydrogel with built-in antibiofilm and antioxidative functions promotes faster healing of infected chronic wounds

Study sheds light on 7-DHC's potential to induce cell death-resistant state in tumors

Lung cancer prediction using biomarkers based on bronchoalveolar fluid microbiomes

Immune checkpoint inhibitor target found to promote skin cancer growth

UTEP researchers unveil promising new weapon against leukemia and lymphoma

Scientists identify critical protein complex for targeted cancer treatment

Boosting egg production in fruit flies through gut bugs

Researchers identify the culprit responsible for harmful inflammation in certain muscular disorders

UB research identifies key mechanism in infantile cystinosis

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News